Furthermore, utilizing an in vitro model with a cell line derived from ovarian cancer, it has been shown that GILZ increased Akt phosphorylation and activity, thereby enhancing proliferation [26]. The gene discussed is TSC22D3; the disease is ovarian carcinoma.